Literature DB >> 34743284

Immunohistochemical Expression of Choline Acetyltransferase and Catecholamine-Synthesizing Enzymes in Head-and-Neck and Thoracoabdominal Paragangliomas and Pheochromocytomas.

Noriko Kimura1, Kiyoto Shiga2, Ken-Ichi Kaneko3, Yutaka Oki4, Chiho Sugisawa5, Jun Saito6, Seiich Tawara7, Hiroshi Akahori8, Susumu Sogabe9, Takafumi Yamashita10, Kazuhiro Takekoshi11, Mitsuhide Naruse12, Takayuki Katabami13.   

Abstract

Paragangliomas (PGLs) are neural-crest-derived, non-epithelial neuroendocrine tumors distributed along the parasympathetic and sympathetic nerves. Head-and-neck PGLs (HNPGLs) have been recognized as nonchromaffin, nonfunctional, parasympathetic tumors. By contrast, thoracoabdominal paragangliomas and pheochromocytomas (PPGLs) are chromaffin, functional, sympathetic tumors. Although HNPGLs and PPGLs have the same histological structure, the zellballen pattern, composed of chief and sustentacular cells surrounded by abundant capillaries, the pathobiological differences between these types of PGLs remain unclarified. To determine the phenotypic features of these PGLs, we performed an immunohistochemical study using specific antibodies against choline acetyltransferase (ChAT), an enzyme involved in acetylcholine synthesis, and enzymes for the catecholamine-synthesis, tyrosine hydroxylase (TH), and dopamine beta-hydroxylase (DBH), in 34 HNPGLs from 31 patients, 12 thoracoabdominal PGLs from 12 patients, and 26 pheochromocytomas from 22 patients. The expression of ChAT, TH, and DBH was 100%, 23%, and 10% in the HNPGLs; 12%, 100%, and 100% in the pheochromocytomas; and 25%, 67%, and 100% in the thoracoabdominal PGLs, respectively. These results designate HNPGLs as acetylcholine-producing parasympathetic tumors, in contrast to PPGLs being catecholamine-producing tumors. The other most frequently used neuroendocrine markers are synaptophysin and chromogranin A expressed 100% and 80%, respectively, and synaptophysin was superior to chromogranin A in HNPGLs. This is the first report of HNPGLs being acetylcholine-producing tumors. Immunohistochemistry of ChAT could be greatly useful for pathologic diagnosis of HNPGL. Whether measurement of acetylcholine levels in the blood or urine could be a tumor marker of HNPGLs should be investigated soon.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Choline acetyltransferase; Dopamine β-hydroxylase; HNPGL; Immunohistochemistry; PPGL; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2021        PMID: 34743284     DOI: 10.1007/s12022-021-09694-x

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  16 in total

Review 1.  Peripheral type of choline acetyltransferase: biological and evolutionary implications for novel mechanisms in cholinergic system.

Authors:  J-P Bellier; H Kimura
Journal:  J Chem Neuroanat       Date:  2011-03-05       Impact factor: 3.052

2.  Choline acetyltransferase immunoreactivity in the human small and large intestine.

Authors:  A J Porter; D A Wattchow; S J Brookes; M Schemann; M Costa
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

Review 3.  Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis.

Authors:  B Wiedenmann; W B Huttner
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

4.  Production of specific antibodies to choline acetyltransferase purified from pig brain.

Authors:  F Eckenstein; Y A Barde; H Thoenen
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

5.  Synaptophysin: a marker protein for neuroendocrine cells and neoplasms.

Authors:  B Wiedenmann; W W Franke; C Kuhn; R Moll; V E Gould
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.

Authors:  Noriko Kimura; Ryoichi Takayanagi; Nae Takizawa; Eiji Itagaki; Takayuki Katabami; Narihiko Kakoi; Hiromi Rakugi; Yukihiro Ikeda; Akiyo Tanabe; Takeshi Nigawara; Sadayoshi Ito; Itaru Kimura; Mitsuhide Naruse
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

7.  Adrenal and extra-adrenal pheochromocytomas: an ultrastructural and formaldehyde-induced fluorescence study with catecholamine content.

Authors:  N Kimura; N Sasano; Y Miura; K Kobayashi
Journal:  Tohoku J Exp Med       Date:  1984-01       Impact factor: 1.848

8.  Immunoelectron microscopic localization of dopamine beta-hydroxylase and chromogranin A in adrenomedullary chromaffin cells.

Authors:  S Matsumoto; K Tanaka; A Yamamoto; H Nakada; M Uchida; Y Tashiro
Journal:  Cell Struct Funct       Date:  1987-10       Impact factor: 2.212

9.  Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour.

Authors:  N Kimura; N Sasano; R Yamada; J Satoh
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

10.  A Novel Antiserum Against a Predicted Human Peripheral Choline Acetyltransferase (hpChAT) for Labeling Neuronal Structures in Human Colon.

Authors:  Jean-Pierre Bellier; Pu-Qing Yuan; Kenichi Mukaisho; Ikuo Tooyama; Yvette Taché; Hiroshi Kimura
Journal:  Front Neuroanat       Date:  2019-04-16       Impact factor: 3.856

View more
  4 in total

Review 1.  Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.

Authors:  Ozgur Mete; Sylvia L Asa; Anthony J Gill; Noriko Kimura; Ronald R de Krijger; Arthur Tischler
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

2.  PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma.

Authors:  Minami Miyauchi; Takumi Akashi; Asuka Furukawa; Keisuke Uchida; Tomoki Tamura; Noboru Ando; Susumu Kirimura; Hiroshi Shintaku; Kurara Yamamoto; Takashi Ito; Keiko Miura; Kou Kayamori; Yosuke Ariizumi; Takahiro Asakage; Atsushi Kudo; Minoru Tanabe; Yasuhisa Fujii; Hironori Ishibashi; Kenichi Okubo; Masanori Murakami; Tetsuya Yamada; Akira Takemoto; Yuan Bae; Yoshinobu Eishi; Kenichi Ohashi
Journal:  Endocr Pathol       Date:  2022-08-27       Impact factor: 4.056

3.  Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report.

Authors:  Fumi Saishouji; Sarie Maeda; Hideaki Hamada; Noriko Kimura; Ai Tamanoi; Saiko Nishida; Masaji Sakaguchi; Motoyuki Igata; Kiho Yokoo; Fumi Kawakami; Eiichi Araki; Tatsuya Kondo
Journal:  BMC Endocr Disord       Date:  2022-07-19       Impact factor: 3.263

Review 4.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.

Authors:  Ozgur Mete; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2022-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.